Start a FREE 2-WEEK TRIAL of Codify by AAPC.
This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0644U only for FusionMRD™ Baseline from Pairidex®. This test analyzes a blood or bone marrow sample to evaluate minimal residual disease (MRD), which means a small amount of cancer that may remain after treatment. The test focuses on rearrangements and includes personalized assay design. The result is reported as baseline quantification, which provides a starting point used for comparison over time.
For clinical responsibility, terminology, tips and additional info
start codify free trial.